Healios KK (HLOSF)
1.80
0.00 (0.00%)
USD |
OTCM |
Oct 20, 16:00
Healios Shareholders Equity (Quarterly) : 53.98M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.98M |
| March 31, 2026 | 47.44M |
| December 31, 2025 | 31.20M |
| September 30, 2025 | 19.87M |
| June 30, 2025 | 8.688M |
| March 31, 2025 | 13.07M |
| December 31, 2024 | 13.13M |
| September 30, 2024 | 11.97M |
| June 30, 2024 | 20.17M |
| March 31, 2024 | 24.45M |
| December 31, 2023 | 27.35M |
| September 30, 2023 | 37.52M |
| June 30, 2023 | 22.44M |
| March 31, 2023 | 28.95M |
| December 31, 2022 | 33.21M |
| September 30, 2022 | 31.70M |
| June 30, 2022 | 32.84M |
| March 31, 2022 | 55.88M |
| December 31, 2021 | 75.02M |
| September 30, 2021 | 94.53M |
| June 30, 2021 | 51.30M |
| March 31, 2021 | 64.39M |
| December 31, 2020 | 75.97M |
| Date | Value |
|---|---|
| September 30, 2020 | 89.90M |
| June 30, 2020 | 108.70M |
| March 31, 2020 | 123.69M |
| December 31, 2019 | 113.50M |
| September 30, 2019 | 95.47M |
| June 30, 2019 | 85.07M |
| March 31, 2019 | 90.20M |
| December 31, 2018 | 98.27M |
| September 30, 2018 | 110.80M |
| June 30, 2018 | 118.68M |
| March 31, 2018 | 147.31M |
| December 31, 2017 | 143.49M |
| September 30, 2017 | 117.88M |
| June 30, 2017 | 117.29M |
| March 31, 2017 | 67.49M |
| December 31, 2016 | 51.39M |
| September 30, 2016 | 62.20M |
| June 30, 2016 | 65.62M |
| March 31, 2016 | 64.47M |
| December 31, 2015 | 77.95M |
| September 30, 2015 | 81.39M |
| June 30, 2015 | 73.03M |
| March 31, 2015 | 20.20M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| 3-D Matrix Ltd. | 45.33M |
| GNI Group Ltd. | 248.83M |
| AnGes, Inc. | 1.266M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alkermes Plc | 1.809B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.24M |
| Total Liabilities (Quarterly) | 88.08M |
| Debt to Equity Ratio | 0.2927 |
| Current Ratio | 2.371 |
| Net Debt Paydown Yield | 0.15% |